We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PLBC:NASDAQPlumas Bancorp analysis

Data as of Oct 17, 2026 - not real-time

Latest price
$62.11
Risk: low
3/10Low risk

Summary

The moving-average structure behind Plumas Bancorp is neutral at $62.11, with no clear ordering between short and long averages. Momentum indicators put RSI at 52.7 (neutral) with MACD reading bullish. Price has been bracketed by support at $59.97 and resistance at $63.42.
On valuation the read is undervalued — earnings multiple of 12.1 versus a 15.8 sector average, below the peer group. The average analyst target implies 9.5% above today's level. Revenue is growing at 43.1% on a 33.5% profit margin. The 2.12% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 13.7%, a beta of 0.32 and a maximum drawdown of 11.1%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 86 on the fear-greed composite.
All three time horizons resolve to buy, carrying 7/10 conviction.

Top market events

  • Plumas Bancorp stock posted USD 1.41 diluted EPS in Q2 2026, USD 0.04 above consensus. Revenue reach
  • Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task.
  • Wall Street expects a year-over-year increase in earnings on higher revenues when Plumas Bancorp PLBC reports results...

Market outlook

Short term

< 1 year

Positive

Model confidence6/106 out of 10

Key factors

  • Trading above the 200-day average of 55.02
  • MACD momentum is positive
  • RSI at 52.7 is in neutral territory

Medium term

1–3 years

Positive

Model confidence6/106 out of 10

Key factors

  • P/E of 12.1 versus sector average of 15.8
  • Trading above the 200-day average of 55.02
  • Analyst targets imply +9.5% versus the current price

Long term

> 3 years

Positive

Model confidence7/107 out of 10

Key factors

  • P/E of 12.1 versus sector average of 15.8
  • Analyst targets imply +9.5% versus the current price
  • Profit margin of 33.5% is healthy

Key metrics

Financial health

Revenue Growth43.10%
Profit Margin33.53%
P/E Ratio12.1
ROE15.41%
ROA1.84%
P/B Ratio1.6
Op. Cash Flow$33.1M
Industry P/E15.8

Technical analysis

TrendNeutral
RSI52.7
Support$59.97
Resistance$63.42
MA 20$61.74
MA 50$61.97
MA 200$55.02
MACDBullish
VolumeStable
Fear & Greed Index85.73

Valuation

Fair Value$99.86
Target Price$68.00
Upside/Downside9.48%
GradeUndervalued
TypeBlend
Dividend Yield2.12%

Risk assessment

Beta0.32
Volatility13.73%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.